OOjer Pharma
Ojer Pharma (Laboratorios Ojer Pharma S.L.) is a Pamplona-based biopharmaceutical company that researches, develops and markets innovative dermatological products for both human and veterinary use, spanning prescription drugs, OTC products, medical devices and cosmetics. Its core technology is a proprietary transparent bioadhesive gel delivery platform that acts as a sustained-release matrix for dermatological actives, improving efficacy while reducing toxicity. Founded in 2005 as a spin-off of the University of Navarra (promoted by FUNA), it has raised roughly €7M across successive capital increases, sells across five continents via partners, and recently obtained marketing authorization for Rhinoheal in Korea with QL Pharma.
Profile updated 12 Aug 2026
Founders
Global models
Investors 7
C
D
E
F
F
I
S